Sumary
DILIsym
- Mechanistic, mathematical quantitative systems toxicology (QST) model
- Constructed to support pharmaceutical risk assessment and decision making
Clinical Application
- DILIsym has been applied to support decisions related to compound DILI risk throughout the clinical development pipeline
- Projects executed with 55+ companies
- DILIsym simulation results have been included in numerous communications with regulatory agencies
Preclinical Application
- Liver Safety+ recently made available
- Provides efficient evaluation of DILI risk for preclinical compounds
- Machine learning utilized to generate key parameters based on compound structure, a la QSAR
DILIsym support enabled via multiple routes
- Simulations Plus services projects
- Direct license of DILIsym
- DILI-sim Consortium membership Liver Safety+
By Scott Q Siler
SOT 64th Annual Meeting and ToxExpo, March 16-20, 2025, Orlando, Florida